Jenny Hsiung 

Director of Business Development & Acquisitions
AbbVie

​

Jenny Hsiung is the Director of Business Development & Acquisitions at AbbVie, where she excels in all aspects of business development transactions. Her expertise includes sourcing opportunities, structuring deals to align with internal and external business needs, and negotiating term sheets and contract provisions successfully. Over the past three years with the AbbVie Immunology BD&A team, Jenny has led numerous transactions, including the acquisitions of Nimble Therapeutics and Celsius Therapeutics. She has also spearheaded the execution of license agreements with FutureGen Biopharmaceutical, OSE Immunotherapeutics, and Parvus Therapeutics. Besides her contributions to Immunology, Jenny oversees all BD&A efforts for Aesthetics.
Before her current role in Business Development, Jenny was with AbbVie's Alliance Management team, where she supported partnerships across Therapeutic Areas and in various stages of development and commercialization. Prior to joining AbbVie, Jenny spent two years in Greater China in Corporate Development roles, including serving as Chief of Staff to the President at TLC BioSciences. She began her career as a Process Engineer at Genentech.
Jenny holds a Master of Engineering (MEng) and a Bachelor of Science (BS) degree in Bioengineering from the University of California, San Diego, and a Master of Business Administration (MBA) degree from Harvard Business School.


 

Speech title & Synopsis

Panel Discussion 1: Business Development & Licensing - Critical Exit Strategy for New Venture

Panelist